Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NanoPac in Locally Advanced Pancreatic Adenocarcinoma
NCT03077685Phase 2Completed
- Sponsor
- NanOlogy
- Start
- Dec 2017
- Primary completion
- Mar 2023
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of NanoPac in pancreatic adenocarcinoma (PDAC), sponsored by NanOlogy. Started Dec 2017; status: completed.
02
Drugs
NanoPac
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT03077685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03077685.